425: Waters-BD Biosciences Merger: Employee Integration FAQ

Waters Corporation addresses employee concerns regarding the upcoming business combination with BD's Biosciences and Diagnostic Solutions businesses, outlining plans for leadership, compensation, benefits, and facilities.

Summary

• Waters Corporation is combining with Augusta SpinCo Corporation (SpinCo), a wholly owned subsidiary of Becton, Dickinson and Company (BD), specifically BD's Biosciences (BDB) & Diagnostic Solutions (DS) business.
• Udit Batra will lead the combined company as President & CEO, and Amol Chaubal will serve as SVP and Chief Financial Officer.
• For at least one year following the transaction close, incoming employees' base salary or wage rate and annual bonus opportunity will remain at least the same as immediately before the transaction closes.
• Outstanding unvested BD long-term incentive (LTI) awards will be converted into unvested Waters LTI awards with the same vesting terms upon employment transition.
• Current BD health & welfare benefit programs will continue through December 31, 2026, with Waters planning to harmonize benefits thereafter.
• Waters will recognize prior service with BD for purposes of eligibility, vesting, equity award exercisability, severance, and paid time off (PTO).
• Current BD holiday schedule and PTO policy will continue uninterrupted through December 31, 2026, with Waters policies becoming eligible from January 1, 2027.
• U.S.-based BD employees will cease participation in the BD 401(k) Plan and become eligible for Waters Retirement Savings Plans at transaction close; non-U.S. BD retirement programs continue until December 31, 2026.
• Specific BD facilities solely supporting BDB and/or DS will transfer to Waters, including sites in Cayey, Puerto Rico; Cockeysville, Maryland; Drachten, Netherlands; Grayson, Georgia; Heidelberg, Germany; Hunt Valley, Maryland; Mebane, North Carolina; Milpitas, California; Quebec, Canada; Salamanca, Spain; San Diego, California; Sparks, Maryland; and Suzhou, China.
• The transaction is expected to close around the end of the first quarter of calendar year 2026.

Sentiment

Score: 6

Explanation: The filing provides reassuring information for employees regarding job security, compensation, and benefits continuity during the merger integration. However, it also highlights numerous risks inherent in such a transaction, leading to a moderately positive but cautious sentiment.

Positives

• Incoming employees' base salary/wage rate and annual bonus opportunity will remain at least the same for at least one year post-close.
• Waters will recognize prior service with BD for benefits, vesting, and PTO purposes.
• Current BD health & welfare benefits, holiday schedule, and PTO policies will continue through December 31, 2026, providing a transition period.
• The transaction is expected to create new career development opportunities for employees of both businesses.
• The combined company will have an expanded portfolio of products to offer customers.

Negatives

• Uncertainty exists regarding staffing decisions and potential changes to job titles/grades beyond the initial executive leadership.
• Changes to health & welfare benefits and PTO policies are expected from January 1, 2027, after the transition period.
• Some countries will not transfer to Waters immediately when the deal closes, in accordance with local laws and practices.
• Potential changes to working locations and policies for remote employees will be determined as part of the integration planning process.

Risks

• One or more closing conditions, including regulatory approvals or Waters stockholder approval, may not be satisfied or waived, or a governmental entity may prohibit, delay, or refuse approval.
• The proposed transaction may not be completed on the terms or in the timeframe expected, or at all.
• Unexpected costs, charges, or expenses may result from the proposed transaction.
• There is uncertainty regarding the expected financial performance of the combined company.
• Failure to realize the anticipated benefits of the proposed transaction, including synergies, due to delays in completion or integration.
• The combined company may face difficulties in implementing its business strategy or achieving revenue and cost synergies.
• Inability to retain and hire key personnel could adversely affect the combined company.
• The occurrence of any event that could give rise to termination of the proposed transaction.
• Stockholder litigation or other litigation, settlements, or investigations may affect the timing or occurrence of the transaction or result in significant costs.
• Evolving legal, regulatory, and tax regimes could impact the transaction or combined company.
• Changes in general economic and/or industry-specific conditions or volatility from tariffs.
• Potential impacts of a U.S. government shutdown, such as one that began in October 2025.
• Actions by third parties, including government agencies, could affect the transaction.
• The anticipated tax treatment of the proposed transaction may not be obtained.
• Greater than expected difficulty in separating the business of SpinCo from the other businesses of BD.
• Disruption of management time from ongoing business operations due to the pendency of the proposed transaction.
• Other effects of the pendency of the proposed transaction on relationships with employees, customers, suppliers, or other counterparties.

Future Outlook

The combined company expects to determine its executive leadership team before the transaction closes. The transaction is anticipated to create new career development opportunities for employees and result in an expanded product portfolio. Waters plans to harmonize benefits over the year following December 31, 2026. The transaction is expected to close around the end of the first quarter of calendar year 2026.

Management Comments

• Integration planning teams are currently working closely with senior leadership to define timelines for important decisions.
• We expect to determine who will serve on the combined company executive leadership team in advance of transaction close.
• Waters recognizes that employees are our greatest asset and is committed to providing competitive compensation programs that reflect employees' hard work, dedication and contributions to the business.
• Our goal is to make the transition seamless for customers.

Industry Context

This communication focuses on internal employee integration aspects of a specific business combination, rather than broader industry trends or competitive analysis. It details the operational and human resources implications of Waters acquiring BD's Biosciences and Diagnostic Solutions businesses.

Management Changes

Stakeholder Impact

• Shareholders: Potential for value creation from the merger, but also exposure to significant integration and regulatory risks, as well as potential litigation.
• Employees: Assurances of compensation and benefits continuity for a period, recognition of prior service, and potential for new career opportunities. However, there is uncertainty regarding future staffing, job roles, and long-term benefit changes.
• Customers: Expected to benefit from an expanded product portfolio post-transaction, with a stated goal of a seamless transition.
• Regulatory Authorities: Involved in the approval process, with the risk that conditions or prohibitions could be imposed.

Next Steps

• Integration planning continues to define timelines for leadership and staffing decisions.
• More information regarding the transition to the Waters LTI plan (including eligibility and timing) will be forthcoming.
• More information about the Waters benefit programs will be provided in the coming months.
• U.S.-based employees will receive communications with more detailed information about Waters Retirement Savings Plans as the close nears.
• All associates on work authorization/visa will receive guidance on visa continuation prior to the close of the transaction.
• Waters and BD will communicate any changes to customers proactively at the time of close.
• Waters intends to file a registration statement on Form S-4, including a preliminary and definitive proxy statement/prospectus.
• SpinCo intends to file a registration statement on Form 10, serving as an information statement/prospectus.

Key Dates

Recommendation

This filing is an employee FAQ providing operational details for an already announced merger. While it offers some clarity on employee compensation and benefits continuity, it does not present new financial performance data or strategic shifts that would fundamentally alter the investment thesis. The extensive list of risks associated with merger integration, regulatory approvals, and potential litigation, as highlighted in the cautionary statements, suggests a 'hold' position until more concrete financial synergies and integration progress are demonstrated, and the transaction officially closes.

Keywords

Waters Corporation, Becton, Dickinson and Company, BD Biosciences, BD Diagnostic Solutions, Merger, Acquisition, Spin-off, Employee Integration, Compensation, Benefits, Corporate Governance, SEC Filing